Company profile for Escend Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Escend Pharmaceuticals, Inc., is developing therapeutics for cancer orphan indications. Our development focus includes therapeutics that kill cancer stem cells in acute myelogenous leukemia and related hematologic malignancies.Escend has created a process to accelerate drug discovery which utilizes integrative biological approaches and risk reduction strategies to identify common cellular pathways among multiple diseases. W...
Escend Pharmaceuticals, Inc., is developing therapeutics for cancer orphan indications. Our development focus includes therapeutics that kill cancer stem cells in acute myelogenous leukemia and related hematologic malignancies.Escend has created a process to accelerate drug discovery which utilizes integrative biological approaches and risk reduction strategies to identify common cellular pathways among multiple diseases. We select small molecule drug candidates with established safety profiles that have not yet achieved US marketing approval. We match these agents based on recent scientific evidence with disease indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3475 Edison Way, Suite R, Menlo Park, CA
Telephone
Telephone
94025(650) 241-9128
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty